Sphingosine 1-phosphate induces MKP-1 expression via p38 MAPK- and CREB-mediated pathways in airway smooth muscle cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 10, 2012, Pages 1658-1665

  Che, Wenchi ^a   Manetsch, Melanie ^a   Quante, Timo ^a   Rahman, Md Mostafizur ^a   Patel, Brijeshkumar S ^a   Ge, Qi ^a   Ammit, Alaina J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Adenylate cyclase; CREB; Cytokine; DUSP 1; P38 MAPK; Sphingolipid

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; SPHINGOSINE 1 PHOSPHATE;

AIRWAY; ARTICLE; CYTOKINE RELEASE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOOTH MUSCLE; UPREGULATION;

ADENYLATE CYCLASE; BRONCHI; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DUAL SPECIFICITY PHOSPHATASE 1; ENZYME ACTIVATION; ENZYME INDUCTION; FEEDBACK, PHYSIOLOGICAL; HUMANS; INTERLEUKIN-6; LYSOPHOSPHOLIPIDS; MAP KINASE SIGNALING SYSTEM; MYOCYTES, SMOOTH MUSCLE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPHINGOSINE; TIME FACTORS; UP-REGULATION;

EID: 84864507046     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.06.011     Document Type: Article

References (29)

1. Yang Y., Uhlig S. The role of sphingolipids in respiratory disease. Ther. Adv. Respir. Dis. 2011, 5:325-344.
2. Lai W.Q., Wong W.S., Leung B.P. Sphingosine kinase and sphingosine 1-phosphate in asthma. Biosci. Rep. 2011, 31:145-150.
3. Ammit A.J., Hastie A.T., Edsall L.C., Hoffman R.K., Amrani Y., Krymskaya V.P., Kane S.A., Peters S.P., Penn R.B., Spiegel S., Panettieri R.A. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. 2001, 15:1212-1214.
4. Rosenfeldt H.M., Amrani Y., Watterson K.R., Murthy K.S., Panettieri R.A., Spiegel S. Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells. FASEB J. 2003, 17:1789-1799.
5. Kume H., Takeda N., Oguma T., Ito S., Kondo M., Ito Y., Shimokata K. Sphingosine 1-phosphate causes airway hyper-reactivity by rho-mediated myosin phosphatase inactivation. J. Pharmacol. Exp. Ther. 2007, 320:766-773.
6. Lai W.Q., Goh H.H., Bao Z., Wong W.S., Melendez A.J., Leung B.P. The role of sphingosine kinase in a murine model of allergic asthma. J. Immunol. 2008, 180:4323-4329.
7. Ediger T.L., Toews M.L. Synergistic stimulation of airway smooth muscle mitogenesis. J. Pharmacol. Exp. Ther. 2000, 294:1076-1082.
8. Roviezzo F., Di Lorenzo A., Bucci M., Brancaleone V., Vellecco V., De Nardo M., Orlotti D., De Palma R., Rossi F., D'Agostino B., Cirino G. Sphingosine-1-phosphate/sphingosine kinase pathway is involved in mouse airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 2007, 36:757-762.
9. J. Chun, S1P-1 Receptor, in: S.J.E. Editors-in-Chief: B.B. David (Eds.) xPharm: The Comprehensive Pharmacology Reference, Elsevier, New York, 2007, pp. 1-6.
10. J. Chun, S1P-2 Receptor, in: S.J.E. Editors-in-Chief: B.B. David (Eds.) xPharm: The Comprehensive Pharmacology Reference, Elsevier, New York, 2007, pp. 1-6.
11. J. Chun, S1P-3 Receptor, in: S.J.E. Editors-in-Chief: B.B. David (Eds.) xPharm: The Comprehensive Pharmacology Reference, Elsevier, New York, 2007, pp. 1-6.
12. J. Chun, S1P-4 Receptor, in: S.J.E. Editors-in-Chief: B.B. David (Eds.) xPharm: The Comprehensive Pharmacology Reference, Elsevier, New York, 2007, pp. 1-4.
13. J. Chun, S1P-5 Receptor, in: S.J.E. Editors-in-Chief: B.B. David (Eds.) xPharm: The Comprehensive Pharmacology Reference, Elsevier, New York, 2007, pp. 1-5.
14. Tolan D., Conway A.-M., Rakhit S., Pyne N., Pyne S. Assessment of the extracellular and intracellular actions of sphingosine 1-phosphate by using the p42/p44 mitogen-activated protein kinase cascade as a model. Cell. Signal. 1999, 11:349-354.
15. Rakhit S., Conway A.-M., Tate R., Bower T., Pyne P.J., Pyne S. Sphingosine 1-phosphate stimulation of the p42/p44 mitogen-activated protein kinase pathway in airway smooth muscle. Biochem. J. 1999, 338:643-649.
16. Wang X., Liu Y. Regulation of innate immune response by MAP kinase phosphatase-1. Cell. Signal. 2007, 19:1372-1382.
17. Chi H., Flavell R.A. Acetylation of MKP-1 and the control of inflammation. Sci. Signal. 2008, 1:e44.
18. Manetsch M., Che W., Seidel P., Chen Y., Ammit A.J. MKP-1: a negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells. Cell. Signal. 2012 Apr, 24(4):907-913.
19. Johnson P.R., McKay K.O., Armour C.L., Black J.L. The maintenance of functional activity in human isolated bronchus after cryopreservation. Pulm. Pharmacol. 1995, 8:43-47.
20. Lasa M., Abraham S.M., Boucheron C., Saklatvala J., Clark A.R. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol. Cell. Biol. 2002, 22:7802-7811.
21. Quante T., Ng Y.C., Ramsay E.E., Henness S., Allen J.C., Parmentier J., Ge Q., Ammit A.J. Corticosteroids reduce IL-6 in ASM cells via up-regulation of MKP-1. Am. J. Respir. Cell Mol. Biol. 2008, 39:208-217.
22. Cho I.J., Woo N.R., Shin I.C., Kim S.G. H89, an inhibitor of PKA and MSK, inhibits cyclic-AMP response element binding protein-mediated MAPK phosphatase-1 induction by lipopolysaccharide. Inflamm. Res. 2009, 58:863-872.
23. Chen P., Li J., Barnes J., Kokkonen G.C., Lee J.C., Liu Y. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J. Immunol. 2002, 169:6408-6416.
24. Burgess J.K., Lee J.H., Ge Q., Ramsay E.E., Poniris M.H., Parmentier J., Roth M., Johnson P.R., Hunt N.H., Black J.L., Ammit A.J. Dual ERK and phosphatidylinositol 3-kinase pathways control airway smooth muscle proliferation: differences in asthma. J. Cell. Physiol. 2008, 216:673-679.
25. Kwak S.P., Hakes D.J., Martell K.J., Dixon J.E. Isolation and characterization of a human dual specificity protein-tyrosine phosphatase gene. J. Biol. Chem. 1994, 269:3596-3604.
26. Sommer A., Burkhardt H., Keyse S.M., Luscher B. Synergistic activation of the mkp-1 gene by protein kinase A signaling and USF, but not c-Myc. FEBS Lett. 2000, 474:146-150.
27. Li J., Gorospe M., Hutter D., Barnes J., Keyse S.M., Liu Y. Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. Mol. Cell. Biol. 2001, 21:8213-8224.
28. Sun H., Charles C.H., Lau L.F., Tonks N.K. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 1993, 75:487-493.
29. Hu J.H., Chen T., Zhuang Z.H., Kong L., Yu M.C., Liu Y., Zang J.W., Ge B.X. Feedback control of MKP-1 expression by p38. Cell. Signal. 2007, 19:393-400.